1. Home
  2. ADAM vs MGTX Comparison

ADAM vs MGTX Comparison

Compare ADAM & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ADAM

Adamas Trust Inc.

HOLD

Current Price

$9.31

Market Cap

826.7M

Sector

Technology

ML Signal

HOLD

Logo MeiraGTx Holdings plc

MGTX

MeiraGTx Holdings plc

HOLD

Current Price

$9.59

Market Cap

909.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADAM
MGTX
Founded
2003
2015
Country
United States
United States
Employees
221
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
826.7M
909.1M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
ADAM
MGTX
Price
$9.31
$9.59
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
7
Target Price
$9.17
$24.57
AVG Volume (30 Days)
531.0K
745.5K
Earning Date
04-29-2026
05-12-2026
Dividend Yield
11.87%
N/A
EPS Growth
N/A
33.02
EPS
N/A
N/A
Revenue
N/A
$81,391,000.00
Revenue This Year
N/A
$141.38
Revenue Next Year
$5.08
N/A
P/E Ratio
$41.51
N/A
Revenue Growth
N/A
144.57
52 Week Low
$6.45
$6.21
52 Week High
$9.32
$11.85

Technical Indicators

Market Signals
Indicator
ADAM
MGTX
Relative Strength Index (RSI) 62.24 51.50
Support Level $7.72 $8.82
Resistance Level N/A $9.65
Average True Range (ATR) 0.19 0.53
MACD -0.01 -0.03
Stochastic Oscillator 76.43 38.78

Price Performance

Historical Comparison
ADAM
MGTX

About ADAM Adamas Trust Inc.

Adamas Trust Inc is an internally-managed REIT for U.S. federal income tax purposes, in the business of acquiring, investing in, financing, and managing mainly mortgage-related single-family and multi-family residential assets. Its objective is to deliver long-term stable distributions to its stockholders over changing economic conditions through a combination of net interest spread and capital gains from a diversified investment portfolio. The company's investment portfolio includes credit-sensitive single-family and multi-family assets.

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.

Share on Social Networks: